MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

Search

Omnicell Inc

Abierto

SectorSanidad

35.51 0.34

Resumen

Variación precio

24h

Actual

Mínimo

34.3

Máximo

35.71

Métricas clave

By Trading Economics

Ingresos

-7.5M

-2M

Ventas

3.4M

314M

P/B

Media del Sector

852.75

66.418

Margen de beneficios

-0.645

Empleados

3,580

EBITDA

-9.8M

21M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+62.36% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-687M

1.5B

Apertura anterior

35.17

Cierre anterior

35.51

Noticias sobre sentimiento de mercado

By Acuity

16%

84%

41 / 349 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 abr 2026, 20:44 UTC

Ganancias

Costco Reports 11% Growth in March Sales

8 abr 2026, 23:51 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 abr 2026, 23:51 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8 abr 2026, 23:36 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Lower on Likely Technical Correction -- Market Talk

8 abr 2026, 22:56 UTC

Charlas de Mercado

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8 abr 2026, 22:45 UTC

Charlas de Mercado

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8 abr 2026, 22:17 UTC

Charlas de Mercado

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8 abr 2026, 21:52 UTC

Noticias de Eventos Importantes

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8 abr 2026, 21:24 UTC

Ganancias

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8 abr 2026, 21:01 UTC

Noticias de Eventos Importantes

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8 abr 2026, 20:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

8 abr 2026, 20:43 UTC

Adquisiciones, fusiones, absorciones

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8 abr 2026, 20:43 UTC

Adquisiciones, fusiones, absorciones

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8 abr 2026, 20:43 UTC

Adquisiciones, fusiones, absorciones

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8 abr 2026, 20:42 UTC

Adquisiciones, fusiones, absorciones

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8 abr 2026, 20:42 UTC

Adquisiciones, fusiones, absorciones

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8 abr 2026, 20:42 UTC

Adquisiciones, fusiones, absorciones

Oracle Responds to TRC Cap Mini-Tender Offer

8 abr 2026, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

8 abr 2026, 20:11 UTC

Adquisiciones, fusiones, absorciones

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8 abr 2026, 20:11 UTC

Adquisiciones, fusiones, absorciones

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8 abr 2026, 20:11 UTC

Adquisiciones, fusiones, absorciones

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8 abr 2026, 19:44 UTC

Ganancias

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8 abr 2026, 19:16 UTC

Charlas de Mercado

Hogs Follow Cutout Prices Lower -- Market Talk

8 abr 2026, 19:02 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

8 abr 2026, 19:02 UTC

Charlas de Mercado

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8 abr 2026, 18:58 UTC

Charlas de Mercado

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8 abr 2026, 18:51 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 abr 2026, 18:51 UTC

Charlas de Mercado

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8 abr 2026, 18:14 UTC

Noticias de Eventos Importantes

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8 abr 2026, 18:05 UTC

Noticias de Eventos Importantes

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

62.36% repunte

Estimación a 12 Meses

Media 57.75 USD  62.36%

Máximo 70 USD

Mínimo 49 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

5

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

41 / 349 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat